p185(neu) Protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma

International Journal of Cancer

Volumn 87, Issue 2, 2000, Pages 186-194

  Nanni, Patrizia ^a,f   Pupa, Serenella M ^b   Nicoletti, Giordano ^c   De Giovanni, Carla ^a   Landuzzi, Lorena ^c   Rossi, Ilaria ^a   Astolfi, Annalisa ^a   Ricci, Cinzia ^a   De Vecchi, Roberta ^b   Invernizzi, Anna M ^b   Di Carlo, Emma ^d   Musiani, Piero ^d   Forni, Guido ^e   Menard, Sylvie ^b   Lollini, Pier Luigi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c INSTITUTO SUPERIOR TÉCNICO   (Portugal)

^d UNIVERSITY OF CHIETI   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f Istituto di Cancerologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CELL PROLIFERATION; CLONOGENESIS; COLONY FORMATION; FEMALE; MOUSE; NONHUMAN; NUDE MOUSE; ONCOGENE NEU; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTO ONCOGENE; TRANSGENIC MOUSE; TUMOR GROWTH;

ANIMALS; ANTIBODIES, MONOCLONAL; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL ADHESION; CELL DIVISION; CELLS, CULTURED; CLONING, MOLECULAR; FEMALE; FLOW CYTOMETRY; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); RATS; RECEPTOR, ERBB-2; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0034662072     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000715)87:2<186::AID-IJC5>3.0.CO;2-1     Document Type: Article

References (31)

1. BAASNER, S., VON MELCHNER, H., KLENNER, T., HILGARD, P. and BECKERS, T., Reversible tumorigenesis in mice by conditional expression of the HER2/c-erbB2 receptor tyrosine kinase. Oncogene, 13, 901-911 (1996).
2. BACUS, S.S., STANCOVSKI, I., HUBERMAN, E., CHIN, D., HURWITZ, E., MILLS, G.B., ULLRICH, A., SELA, M. and YARDEN, Y., Tumor-inhibitory monoclonal antibodies to the HER-2/Neu receptor induce differentiation of human breast cancer cells. Cancer Res., 52, 2580-2589 (1992).
3. BOGGIO, K., and 16 OTHERS, Interleukin-12 mediated prevention of spontaneous mammary adenocarcinomas in two lines of HER-2/neu transgenic mice. J. exp. Med., 188, 589-596 (1998).
4. COUSSENS, L., YANG-FENG, T.L., LIAO, Y.C., CHEN, E., GRAY, A., MCGRATH, J., SEEBURG, P.H., LIBERMANN, T.A., SCHLESSINGER, J. and FRANCKE, U., Tyrosine kinase receptor with extensive homology to EGF receptor shares chromosomal location with neu oncogene. Science, 230, 1132-1139 (1985).
5. DE GIOVANNI, C., PALMIERI, G., NICOLETTI, G., LANDUZZI, L., SCOTLANDI, K., BONTADINI, A., TAZZARI, P.-L., SENSI, M., SANTONI, A., NANNI, P. and LOLLINI, P.-L., Immunological and non-immunological influence of H-2Kb gene transfection on the metastatic ability of B16 melanoma cells. Int. J. Cancer, 48, 270-276 (1991).
6. DEMICHELI, R., TERENZIANI, M., VALAGUSSA, P., MOLITERNI, A., ZAMBETTI, M. and BONADONNA, G., Local recurrences following mastectomy: support for the concept of tumor dormancy. J. natl. Cancer Inst., 86, 45-48 (1994).
7. DI FIORE, P.P., PIERCE, J.H., KRAUS, M.H., SEGATTO, O., KING, C.R. and AARONSON, S.A., erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science, 237, 178-182 (1987).
8. DRIOUCH, K., CHAMPEME, M.H., BEUZELIN, M., BIECHE, I. and LIDEREAU, R., Classical gene amplifications in human breast cancer are not associated with distant solid metastases. Brit. J. Cancer, 76, 784-787 (1997).
9. FELIP, E., DEL CAMPO, J.M., RUBIO, D., VIDAL, M.T., COLOMER, R. and BERMEJO, B., Overexpression of c-erbB-2 in epithelial ovarian cancer. Prognostic value and relationship with response to chemotherapy. Cancer, 75, 2147-2152 (1995).
10. GIANI, C., CASALINI, P., PUPA, S.M., DE VECCHI, R., ARDINI, E., COLNAGHI, M.I., GIORDANO, A. and MENARD, S., Increased expression of c-crbB-2 in hormone-dependent breast cancer cells inhibits cell growth and induces differentiation. Oncogene, 17, 425-432 (1998).
11. GUY, C.T., WEBSTER, M.A., SCHALLER, M., PARSONS, T.J., CARDIFF, R.D. and MULLER, W.J., Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. nat. Acad. Sci. (Wash. D.C.), 89, 10578-10582 (1992).
12. HARTMANN, L.C., INGLE, J.N., WOLD, L.E., FARR, G.H. JR, GRILL, J.P., SU, J.Q., MAIHLE, N.J., KROOK, J.E., WITZIG, T.E. and ROCHE, P.C., Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocol. Cancer, 74, 2956-2963 (1994).
13. KACINSKI, B.M., NGUYEN, J. and CARTER, D., Expression of neu antigen in normal lactating and prepartum mammary epithelial cells. J. Soc. Gynecol. Inves., 2, 51-56 (1995).
14. KERN, J.A., SLEBOS, R.J., TOP, B., RODENHUIS, S., LAGER, D., ROBINSON, R.A., WEINER, D. and SCHWARTZ, D.A., C-erbB-2 expression and codon 12 K-ras mutations both predict shortened survival for patients with pulmonary adenocarcinomas. J. Clin. Invest., 93, 516-520 (1994).
15. KING, C.R., KRAUS, M.H. and AARONSON, S.A., Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science, 229, 974-976 (1985).
16. KOKAI, Y., COHEN, J.A., DREBIN, J.A. and GREENE, M.I., Stage- and tissue-specific expression of the neu oncogene in rat development. Proc. nat. Acad. Sci. (Wash. D.C.), 84, 8498-8501 (1987).
17. KOSCIELNY, S., TERRIER, P., SPIELMANN, M. and DELARUE, J.-C., Prognostic importance of low c-erbB2 expression in breast tumors. J. nat. Cancer Inst. 90, 712-712 (1998).
18. LOLLINI, P.-L., NICOLETTI, G., LANDUZZI, L., DE GIOVANNI, C., ROSSI, I., DI CARLO, E., MUSIANI, P., MULLER, W.J. and NANNI, P., Down regulation of major histocompatibility complex class I expression in mammary carcinoma of HER-2/neu transgenic mice. Int. J. Cancer. 77, 937-941 (1998).
19. MULLER, W.J., SINN, E., PATTENGALE, P.K., WALLACE, R. and LEDER, P., Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell, 54, 105-115 (1988).
20. PELES, E., BEN-LEVY, R., TZAHAR, E., LIU, N., WEN, D. and YARDEN, Y., Cell-type specific interaction of Neu differentiation factor (NDF/heregulin) with Neu/HER-2 suggests complex ligand-receptor relationships. EMBO J., 12, 961-971 (1993).
21. PUPA, S.M., BUFALINO, R., INVERNIZZI, A.M., ANDREOLA, S., RILKE, F., LOMBARDI. L., COLNAGHI, M.I. and MENARD, S., Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas. J. Clin. Oncol., 14, 85-94 (1996).
22. REVILLION, F., BONNETERRE, J. and PEYRAT, J.P., ERBB2 oncogene in human breast cancer and its clinical significance. Eur. J. Cancer, 34, 791-808 (1998).
23. RILKE, F., COLNAGHI, M.I., CASCINELLI, N., ANDREOLA, S., BALDINI, M.T., BUFALINO, R., DELLA, PORTA, G., MENARD, S., PIEROTTI, M.A. and TESTORI, A., Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int. J. Cancer, 49, 44-49 (1991).
24. SCHONBORN, I., ZSCHIESCHE, W., SPITZER, E., MINGUILLON, C., MOHNER, M., EBELING, K. and GROSSE, R., C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high risk. Breast Cancer Res. Treat., 29, 287-295 (1994).
25. SESHADRI, R., FIRGAIRA, F.A., HORSFALL, D.J., MCCAUL, K., SETLUR, V. and KITCHEN, P., Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group. J. clin. Oncol., 11, 1936-1942 (1993).
26. SLAMON, D.J., CLARK, G.M., WONG, S.G., LEVIN, W.J., ULLRICH, A. and MCGUIRE, W.L., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science, 235, 177-182 (1987).
27. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J. and ULLRICH, A., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
28. TAN, M., YAO, J. and YU, D., Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. Cancer Res., 57, 1199-1205 (1997).
29. TOIKKANEN, S., HELIN, H., ISOLA, J. and JOENSUU, H., Prognostic significance of HER-2 oncoprotein expression in breast cancer: a 30-year follow-up. J. clin. Oncol., 10, 1044-1048 (1992).
30. UHR, J.W., SCHUERMANN, R.H., STREET, N.E. and VITETTA, E.S., Cancer dormancy: opportunities for new therapeutic approaches. Nature Med., 3, 505-509 (1997).
31. YU, D., WANG, S.S., DULSKI, K.M., TSAI, C.M., NICOLSON, G.L. and HUNG, M.C., c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res., 54, 3260-3266 (1994).